Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
General & GI surgery · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Xie Xiaoming谢小明

Chief Physician · Professor
Department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Xie Xiaoming

Professional overview

Xie Xiaoming is a Chief Physician and Professor at Sun Yat-sen University Cancer Center, specializing in breast cancer. Xie serves as Director of the Breast Surgery Department and leads research and clinical work in breast disease diagnosis and treatment.

SpecialtyGeneral & GI surgery
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentBreast Surgery Department
HospitalSun Yat-sen University Cancer Center
CityGuangzhou
Hospital roleDirector of the Breast Surgery Department

Department leadership

Department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Early diagnosis of breast cancerFocus on early detection of breast cancer
Surgical treatment of breast cancerFocus on surgical management of breast cancer
Comprehensive treatment of breast cancerFocus on multimodal, integrated approaches to breast cancer care
Breast reconstructionFocus on post-mastectomy breast reconstruction

Background

  • 2008Returned to China and co-founded the Breast Surgery Department at the Cancer Center with Professor Yang Mingtian; appointed Director
  • 2009Established the Tumor Biotechnology Research Laboratory at the State Key Laboratory of Oncology in South China and served as Director; co-established the China-France Joint Laboratory of Cancer Genetics with Centre Jean Perrin and served as Director

Experience & recognition

  • Over 70 publications, including more than 50 in SCI-indexed journals
  • First or corresponding author of papers with cumulative impact factor over 90, including one in Cancer Cell (2007, IF 24.9)
  • Holds or has applied for 11 patents in China and the US
  • Developed 10 preclinical therapeutic products, including one approved by the FDA for Phase I clinical trial
  • Recipient of AstraZeneca Award (2005) and First Prize at the 10th Annual Oncology Research Seminar (2001)

Professional roles

  • Member, Chinese Medical Association (CMA) Oncology Branch Breast Cancer Committee
  • Member, Chinese Medical Association (CMA) Plastic Surgery Branch Tumor Plastic Surgery Committee
  • Standing Committee Member, Chinese Research Hospital Association Breast Disease Committee
  • Vice Chair, Chinese Association of Eugenics and Health Care Breast Health Committee
  • Member, China Anti-Cancer Association (CACA) Tumor Metabolism Committee
  • Member, China Anti-Cancer Association (CACA) Tumor Plastic Surgery Committee
  • Standing Committee Member, Guangdong Medical Association Breast Disease Branch
  • Standing Committee Member, Guangdong Anti-Cancer Association Breast Cancer Committee

Frequently asked questions

What does Dr. Xie Xiaoming specialize in?

Early diagnosis, surgical treatment, comprehensive treatment, and breast reconstruction for breast cancer

Which hospital and department is Dr. Xie Xiaoming in?

Breast Surgery Department at Sun Yat-sen University Cancer Center

Sources

Dr. Xie Xiaoming has not reviewed this page.